Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes

被引:33
作者
Nia, Peyman Sardari
Colpaert, Cecile
Vermeulen, Peter
Weyler, Joost
Pezzella, Francesco
Van Schil, Paul
Van Marck, Eric
机构
[1] Univ Antwerp Hosp, Dept Thorac & Vasc Surg, Antwerp, Belgium
[2] Univ Antwerp Hosp, Dept Pathol, Antwerp, Belgium
[3] Univ Antwerp Hosp, Dept Epidemiol, Antwerp, Belgium
[4] Univ Antwerp Hosp, Dept Social Med, Antwerp, Belgium
[5] John Radcliffe Hosp, Canc Res Tumor Pathol Grp, Oxford OX3 9DU, England
关键词
D O I
10.1016/j.athoracsur.2007.08.054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. We have recently shown the prognostic value of growth pattern classification in non-small cell lung cancer. The aim of this study is to validate the hypothesis that these growth patterns have a distinct angiogenic and proliferative profile. Methods. Hematoxylin-eosin stained tissue sections of 239 patients with non-small cell lung cancer were classified into growth patterns. One representative tissue section per patient was double immunostained with CD34 and Ki-67 antibodies. Endothelial cell proliferation fraction, tumor cell proliferation fraction, microvessel density, and Chalkley count were assessed at the invading front and the center of the selected tumor section. Results. According to the growth pattern classification, 161 patients (67.4%) had a destructive, 33 (13.8%) a papillary, and 45 (18.8%) an alveolar growth pattern. There were significant differences in endothelial cell proliferation fraction (p < 0.001), tumor cell proliferation fraction (p < 0.001), microvessel density (p < 0.001), and Chalkley count (p < 0.001) between the growth patterns. Multiple Cox regression analysis showed that a low endothelial cell proliferation fraction was consistently an independent prognostic factor for overall poor (hazard ratio = 0.93; confidence interval: 0.88 to 0.97, p = 0.002) and disease-free survival (hazard ratio = 0.94; confidence interval: 0.89 to 0.98, p = 0.007). Conclusions. Growth patterns have a distinct angiogenic and proliferative profile. In non-small cell lung cancer, a low degree of angiogenesis (a low endothelial cell proliferation fraction) is associated with poor prognosis.
引用
收藏
页码:395 / 405
页数:11
相关论文
共 28 条
[11]  
Koukourakis MI, 2000, CANCER RES, V60, P3088
[12]   Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer [J].
Matsuyama, K ;
Chiba, Y ;
Sasaki, M ;
Tanaka, H ;
Muraoka, R ;
Tanigawa, N .
ANNALS OF THORACIC SURGERY, 1998, 65 (05) :1405-1409
[13]   Revisions in the International System for Staging Lung Cancer [J].
Mountain, CF .
CHEST, 1997, 111 (06) :1710-1717
[14]   Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer [J].
Nia, PS ;
Colpaert, C ;
Blyweert, B ;
Kui, B ;
Vermeulen, P ;
Ferguson, M ;
Hendriks, J ;
Weyler, J ;
Pezzella, F ;
Van Marck, E ;
Van Schil, P .
BRITISH JOURNAL OF CANCER, 2004, 91 (07) :1293-1300
[15]  
NIA PS, 2005, CLIN LUNG CANCER, V6, P217
[16]  
Offersen BV, 2001, CANCER, V91, P1500, DOI 10.1002/1097-0142(20010415)91:8<1500::AID-CNCR1158>3.0.CO
[17]  
2-M
[18]   Tumor angiogenesis and recurrence in stage I non-small cell lung cancer [J].
Ohta, Y ;
Tomita, Y ;
Oda, M ;
Watanabe, S ;
Murakami, S ;
Watanabe, Y .
ANNALS OF THORACIC SURGERY, 1999, 68 (03) :1034-1038
[19]   Global cancer statistics, 2002 [J].
Parkin, DM ;
Bray, F ;
Ferlay, J ;
Pisani, P .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) :74-108
[20]   Immunocytochemical markers in stage I lung cancer: Relevance to prognosis [J].
Pastorino, U ;
Andreola, S ;
Tagliabue, E ;
Pezzella, F ;
Incarbone, M ;
Sozzi, G ;
Buyse, M ;
Menard, S ;
Pierotti, M ;
Rilke, F .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (08) :2858-2865